Romark Laboratories L.c. - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsRomark Laboratories L.c.

Romark Laboratories L.c.

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

No data

Company Revenue

No data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Alinia	Nitazoxanide	2004-07-21		Diarrhea , Giardiasis , Cryptosporidiosis , Protozoan infections

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

insulin resistance

,

lipid metabolism disorders

,

contraception behavior

,

,

heart disease risk factors

,

gender dysphoria

,

,

bronchiolitis obliterans syndrome

,

amyotrophic lateral sclerosis

,

latent tuberculosis

,

,

parkinson disease

,

alzheimer disease

,

gender identity

,

kidney diseases

,

,

behavior and behavior mechanisms

,

biliary liver cirrhosis

,

pharmacokinetics

,

directly observed therapy

,

metabolic diseases

,

ebola hemorrhagic fever

,

,

aids-related lymphoma

,

pulmonary tuberculosis

,

leukoencephalopathies

,

progressive multifocal leukoencephalopathy

,

htlv-ii infections

,

amphetamine-related disorders

,

b-cell chronic lymphocytic leukemia

,

large b-cell lymphoma diffuse

,

b-cell leukemia

,

nutrition disorders

,

appendiceal neoplasms

,

,

relapsing-remitting multiple sclerosis

,

lung transplantation

,

patient acceptance of health care

,

multiple sclerosis

,

post-acute covid-19 syndrome

,

lymphoproliferative disorders

,

,

immunologic deficiency syndromes

,

,

,

,

,

liver transplantation

,

chronic hepatitis d

,

metabolic syndrome

,

pseudomyxoma peritonei

,

hyperlipidemias

,

antibiotic prophylaxis

,

,

severe acute respiratory syndrome

,

coronavirus infections

,

hiv seronegativity

,

b-cell lymphoma

,

chronic kidney failure

,

viral hepatitis human

,

treatment adherence and compliance

,

,

occupational injuries

,

,

,

,

,

,

,

,

chronic hepatitis b

,

,

,

acquired immunodeficiency syndrome

,

chronic hepatitis

,

,

healthy volunteers/patients

,

communicable diseases

,

,

,

,

,

,

sexually transmitted diseases

,

medication adherence

,

herpesviridae infections

,

liver cirrhosis

,

hepatocellular carcinoma

,

liver neoplasms

,

,

hepatitis b virus

,

renal insufficiency

,

,

hiv seropositivity

,

cardiovascular diseases

,

,

,

chronic hepatitis c

,

,

opioid-related disorders

,

substance-related disorders

,

,

drug interactions

,

highly active antiretroviral therapy

,

metabolic bone diseases

,

,

,

,

,

,

end stage liver disease

,

,

acute-on-chronic liver failure

,

disease progression

,

chronic renal insufficiency

,

,

cognitive dysfunction

,

hepatic insufficiency

,

,

non-alcoholic fatty liver disease

,

persistent infection

,

,

,

,

,

,

anxiety disorders

,

hiv-associated lipodystrophy syndrome

,

recreational drug use

,

bacterial sexually transmitted diseases

,

,

,

drug-related side effects and adverse reactions

,

patient compliance

,

body weight changes

,

,

,

,

,

viral sexually transmitted diseases

,

alcohol drinking

,

epstein-barr virus infections

,

neurotoxicity syndromes

,

physiologic calcification

,

pathologic bone demineralization

,

,

,

congenital abnormalities

,

non-hodgkin lymphoma

,

,

,

,

morphine dependence

,

organ transplantation

,

sleep wake disorders

,

central nervous system diseases

,

nervous system diseases

,

,

hormone replacement therapy

,

kidney transplantation

,

sexual behavior

,

papillomaviridae

,

cytomegalovirus infections

,

opportunistic infections

,

coronary disease

,

coronary artery disease

,

myocardial ischemia

,

atherosclerosis

,

immunosuppression therapy

,

,

,

,

aids-related opportunistic infections

,

vascular diseases

,

cardiovascular abnormalities

,

burkitt lymphoma

,

,

vitamin d deficiency

,

,

drug resistance

,

hematologic neoplasms

,

hematologic diseases

,

,

sleep initiation and maintenance disorders

,

,

,

risk reduction behavior

,

,

sustained virologic response

,

,

acute kidney injury

,

portal hypertension

,

esophageal and gastric varices

,

,

retinal diseases

,

,

chlamydia infections

,

female genital diseases

,

genital diseases

,

,

chemical and drug induced liver injury

,

immune reconstitution inflammatory syndrome

,

,

combination drug therapy

,

,

high-risk pregnancy

,

,

,

,

adolescent behavior

,

,

,

,

platelet aggregation

,

renal tubular acidosis

,

,

focal segmental glomerulosclerosis

,

hypercholesterolemia

,

hypertriglyceridemia

,

breast neoplasms

,

psychological stress

,

physiological stress

,

caregiver burden

,

,

,

foot dermatoses

,

,

,

mental disorders

,

wounds and injuries

,

spinal cord injuries

,

premature birth

,

,

,

patient satisfaction

,

treponemal infections

,

,

papillomavirus infections

,

rna virus infections

,

blood-borne infections

,

perinatal mortality

,

postoperative pain

,

,

,

vulvar vestibulitis

,

,

,

neuromuscular diseases

b-cell lymphoma marginal zone

,

follicular lymphoma

,

mantle-cell lymphoma

,

waldenstrom macroglobulinemia

,

interdigitating dendritic cell sarcoma

,

b-cell chronic lymphocytic leukemia

,

,

,

lymphoid leukemia

,

non-hodgkin lymphoma

,

b-cell lymphoma

,

non-small-cell lung carcinoma

,

hematologic diseases

,

,

partial epilepsies

hepatitis b virus

,

chronic hepatitis b

,

,

,

human influenza

healthy volunteers/patients

healthy volunteers/patients

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use